| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 26 | 2018 | 66 | 6.310 |
Why?
|
| Interpeduncular Nucleus | 8 | 2024 | 21 | 4.770 |
Why?
|
| Nicotine | 21 | 2021 | 113 | 4.750 |
Why?
|
| Ventral Tegmental Area | 11 | 2023 | 37 | 3.450 |
Why?
|
| Dopamine | 10 | 2024 | 102 | 2.760 |
Why?
|
| Habenula | 5 | 2023 | 15 | 2.510 |
Why?
|
| Substance Withdrawal Syndrome | 7 | 2021 | 119 | 2.380 |
Why?
|
| Nicotinic Agonists | 11 | 2017 | 39 | 2.290 |
Why?
|
| Dopaminergic Neurons | 7 | 2023 | 36 | 2.130 |
Why?
|
| Ethanol | 9 | 2018 | 309 | 2.090 |
Why?
|
| Reward | 8 | 2023 | 85 | 1.950 |
Why?
|
| GABAergic Neurons | 5 | 2024 | 31 | 1.510 |
Why?
|
| Mice | 44 | 2024 | 10316 | 1.490 |
Why?
|
| Mesencephalon | 3 | 2020 | 25 | 1.310 |
Why?
|
| Nerve Net | 3 | 2020 | 93 | 1.300 |
Why?
|
| Exploratory Behavior | 2 | 2020 | 33 | 1.250 |
Why?
|
| Animals | 54 | 2024 | 19705 | 1.180 |
Why?
|
| Tobacco Use Disorder | 4 | 2018 | 243 | 1.180 |
Why?
|
| Acetylcholine | 4 | 2023 | 41 | 1.130 |
Why?
|
| Anxiety | 5 | 2023 | 388 | 1.130 |
Why?
|
| Mice, Inbred C57BL | 22 | 2023 | 3240 | 1.100 |
Why?
|
| Protein Subunits | 3 | 2016 | 165 | 0.930 |
Why?
|
| Alcohol Drinking | 3 | 2016 | 291 | 0.800 |
Why?
|
| Neurons | 7 | 2014 | 865 | 0.790 |
Why?
|
| Motivation | 2 | 2023 | 275 | 0.750 |
Why?
|
| Cholinergic Neurons | 2 | 2023 | 10 | 0.730 |
Why?
|
| Corticotropin-Releasing Hormone | 3 | 2016 | 34 | 0.720 |
Why?
|
| Mice, Knockout | 11 | 2019 | 2000 | 0.640 |
Why?
|
| Locomotion | 5 | 2019 | 111 | 0.600 |
Why?
|
| Benzazepines | 3 | 2013 | 21 | 0.540 |
Why?
|
| Choice Behavior | 1 | 2017 | 78 | 0.530 |
Why?
|
| Mecamylamine | 5 | 2021 | 14 | 0.500 |
Why?
|
| Up-Regulation | 2 | 2015 | 367 | 0.490 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2016 | 810 | 0.470 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 187 | 0.470 |
Why?
|
| Mice, Transgenic | 8 | 2023 | 1207 | 0.460 |
Why?
|
| Signal Transduction | 9 | 2019 | 2905 | 0.460 |
Why?
|
| Synaptic Transmission | 4 | 2024 | 147 | 0.450 |
Why?
|
| Male | 25 | 2023 | 27952 | 0.440 |
Why?
|
| Behavior, Animal | 2 | 2013 | 219 | 0.440 |
Why?
|
| Nicotinic Antagonists | 6 | 2016 | 19 | 0.440 |
Why?
|
| Quinoxalines | 2 | 2011 | 35 | 0.420 |
Why?
|
| Ribonuclease III | 1 | 2013 | 82 | 0.420 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 79 | 0.410 |
Why?
|
| Nucleus Accumbens | 3 | 2023 | 43 | 0.360 |
Why?
|
| Potassium Channels, Voltage-Gated | 2 | 2001 | 31 | 0.350 |
Why?
|
| Potassium Channels | 2 | 2001 | 53 | 0.350 |
Why?
|
| Action Potentials | 4 | 2017 | 102 | 0.340 |
Why?
|
| Cocaine | 3 | 2019 | 99 | 0.330 |
Why?
|
| Corpus Striatum | 3 | 2019 | 93 | 0.330 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 20 | 0.320 |
Why?
|
| Parkinsonian Disorders | 1 | 2009 | 14 | 0.320 |
Why?
|
| Tyrosine 3-Monooxygenase | 4 | 2015 | 33 | 0.310 |
Why?
|
| Hypothermia | 2 | 2016 | 19 | 0.310 |
Why?
|
| Dopamine Agonists | 4 | 2013 | 20 | 0.310 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 418 | 0.310 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 27 | 0.310 |
Why?
|
| Ion Channels | 2 | 2014 | 88 | 0.310 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2015 | 52 | 0.290 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 117 | 0.260 |
Why?
|
| Drug Interactions | 3 | 2018 | 116 | 0.260 |
Why?
|
| Drug Tolerance | 2 | 2008 | 30 | 0.250 |
Why?
|
| Rats | 7 | 2020 | 1911 | 0.240 |
Why?
|
| Lung Neoplasms | 5 | 2011 | 604 | 0.240 |
Why?
|
| Dihydro-beta-Erythroidine | 2 | 2015 | 4 | 0.230 |
Why?
|
| Tegmentum Mesencephali | 1 | 2024 | 6 | 0.230 |
Why?
|
| Sucrose | 1 | 2023 | 28 | 0.220 |
Why?
|
| Amphetamine | 2 | 2013 | 11 | 0.210 |
Why?
|
| Acetylcholinesterase | 1 | 2023 | 15 | 0.210 |
Why?
|
| Cholinergic Agents | 1 | 2023 | 9 | 0.210 |
Why?
|
| Varenicline | 3 | 2016 | 11 | 0.210 |
Why?
|
| Organ Culture Techniques | 3 | 2019 | 68 | 0.210 |
Why?
|
| Gene Knock-In Techniques | 2 | 2013 | 34 | 0.210 |
Why?
|
| Central Nervous System Depressants | 2 | 2016 | 42 | 0.210 |
Why?
|
| Semen | 1 | 2023 | 42 | 0.200 |
Why?
|
| Mutation | 5 | 2015 | 2462 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2020 | 1472 | 0.200 |
Why?
|
| Sex Characteristics | 2 | 2019 | 199 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2020 | 627 | 0.180 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2020 | 4 | 0.180 |
Why?
|
| Raphe Nuclei | 1 | 2020 | 6 | 0.180 |
Why?
|
| KCNQ1 Potassium Channel | 3 | 2009 | 15 | 0.170 |
Why?
|
| Point Mutation | 3 | 2013 | 161 | 0.170 |
Why?
|
| Multigene Family | 2 | 2010 | 92 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2019 | 1555 | 0.160 |
Why?
|
| Vibrissae | 1 | 2019 | 5 | 0.160 |
Why?
|
| Chemokine CX3CL1 | 1 | 2019 | 6 | 0.160 |
Why?
|
| RNA | 1 | 2023 | 405 | 0.160 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2019 | 11 | 0.160 |
Why?
|
| ADAM10 Protein | 1 | 2019 | 11 | 0.160 |
Why?
|
| Sensorimotor Cortex | 1 | 2019 | 4 | 0.160 |
Why?
|
| Analysis of Variance | 2 | 2011 | 592 | 0.160 |
Why?
|
| Touch | 1 | 2019 | 27 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2019 | 850 | 0.160 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 69 | 0.160 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2019 | 37 | 0.150 |
Why?
|
| Leucine | 2 | 2010 | 61 | 0.140 |
Why?
|
| Dopamine Antagonists | 1 | 2017 | 15 | 0.140 |
Why?
|
| Optogenetics | 1 | 2017 | 22 | 0.140 |
Why?
|
| Maze Learning | 1 | 2017 | 50 | 0.140 |
Why?
|
| Body Temperature | 2 | 2016 | 45 | 0.140 |
Why?
|
| Receptors, Dopamine | 1 | 2017 | 16 | 0.140 |
Why?
|
| Paternal Exposure | 1 | 2017 | 5 | 0.140 |
Why?
|
| Paternal Inheritance | 1 | 2017 | 6 | 0.140 |
Why?
|
| Xenobiotics | 1 | 2017 | 13 | 0.140 |
Why?
|
| Binge Drinking | 1 | 2017 | 27 | 0.130 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 476 | 0.130 |
Why?
|
| Gene Silencing | 1 | 2019 | 378 | 0.130 |
Why?
|
| Organ Specificity | 2 | 2014 | 183 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2010 | 679 | 0.130 |
Why?
|
| Brain | 8 | 2014 | 1495 | 0.130 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 298 | 0.130 |
Why?
|
| Microglia | 1 | 2019 | 230 | 0.130 |
Why?
|
| Humans | 18 | 2020 | 59737 | 0.130 |
Why?
|
| Reflex, Righting | 1 | 2016 | 1 | 0.130 |
Why?
|
| Cell Count | 2 | 2019 | 127 | 0.130 |
Why?
|
| DNA, Ribosomal | 1 | 2015 | 29 | 0.130 |
Why?
|
| Dorsal Raphe Nucleus | 1 | 2015 | 2 | 0.120 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2015 | 2 | 0.120 |
Why?
|
| Compulsive Behavior | 1 | 2015 | 5 | 0.120 |
Why?
|
| Serotonergic Neurons | 1 | 2015 | 5 | 0.120 |
Why?
|
| Drug-Seeking Behavior | 1 | 2015 | 7 | 0.120 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 143 | 0.120 |
Why?
|
| Calbindin 2 | 1 | 2015 | 3 | 0.120 |
Why?
|
| Calbindins | 1 | 2015 | 10 | 0.120 |
Why?
|
| Glutamate Decarboxylase | 1 | 2015 | 22 | 0.120 |
Why?
|
| Conditioning, Operant | 1 | 2015 | 27 | 0.120 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2015 | 24 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2017 | 209 | 0.120 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 128 | 0.120 |
Why?
|
| Female | 9 | 2019 | 30925 | 0.120 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 691 | 0.110 |
Why?
|
| Emotions | 1 | 2016 | 215 | 0.110 |
Why?
|
| Genotype | 3 | 2013 | 621 | 0.110 |
Why?
|
| Rhodopsin | 1 | 2013 | 13 | 0.110 |
Why?
|
| Somatostatin | 1 | 2013 | 19 | 0.110 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2095 | 0.110 |
Why?
|
| Genetic Variation | 1 | 2015 | 357 | 0.110 |
Why?
|
| Phototherapy | 1 | 2013 | 34 | 0.110 |
Why?
|
| Spermatozoa | 1 | 2015 | 253 | 0.110 |
Why?
|
| Genome | 1 | 2015 | 257 | 0.110 |
Why?
|
| Substantia Nigra | 1 | 2013 | 14 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2014 | 248 | 0.110 |
Why?
|
| Synaptosomes | 1 | 2013 | 16 | 0.110 |
Why?
|
| Glutamic Acid | 1 | 2013 | 95 | 0.100 |
Why?
|
| Models, Genetic | 2 | 2011 | 255 | 0.100 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2013 | 76 | 0.100 |
Why?
|
| DNA Repeat Expansion | 1 | 2013 | 53 | 0.100 |
Why?
|
| Light | 1 | 2013 | 198 | 0.100 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 360 | 0.100 |
Why?
|
| Drug Synergism | 1 | 2012 | 132 | 0.100 |
Why?
|
| Learning | 1 | 2013 | 172 | 0.100 |
Why?
|
| Xenopus laevis | 2 | 2003 | 67 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2011 | 482 | 0.090 |
Why?
|
| Luminescent Measurements | 1 | 2011 | 39 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 4 | 2023 | 653 | 0.090 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 41 | 0.090 |
Why?
|
| Frontotemporal Dementia | 1 | 2013 | 136 | 0.090 |
Why?
|
| Phenotype | 2 | 2013 | 1142 | 0.090 |
Why?
|
| KCNQ Potassium Channels | 2 | 2001 | 3 | 0.090 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2011 | 3 | 0.090 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bicuculline | 1 | 2011 | 6 | 0.090 |
Why?
|
| Microdissection | 1 | 2011 | 5 | 0.090 |
Why?
|
| Atropine | 1 | 2011 | 13 | 0.090 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2011 | 30 | 0.090 |
Why?
|
| Cell Size | 1 | 2011 | 40 | 0.090 |
Why?
|
| Patch-Clamp Techniques | 1 | 2011 | 127 | 0.090 |
Why?
|
| Electric Stimulation | 1 | 2011 | 132 | 0.090 |
Why?
|
| Muscarinic Antagonists | 1 | 2011 | 32 | 0.090 |
Why?
|
| Drinking Behavior | 1 | 2010 | 9 | 0.090 |
Why?
|
| Alanine | 1 | 2010 | 49 | 0.090 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2010 | 37 | 0.090 |
Why?
|
| Pyridines | 2 | 2016 | 99 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2011 | 195 | 0.080 |
Why?
|
| Oocytes | 2 | 2003 | 194 | 0.080 |
Why?
|
| Drug Combinations | 1 | 2010 | 147 | 0.080 |
Why?
|
| Catalepsy | 1 | 2009 | 2 | 0.080 |
Why?
|
| Cholinergic Fibers | 1 | 2009 | 4 | 0.080 |
Why?
|
| Quinpirole | 1 | 2009 | 5 | 0.080 |
Why?
|
| Epilepsy, Generalized | 1 | 2009 | 4 | 0.080 |
Why?
|
| Muscle Rigidity | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cell Line | 4 | 2010 | 1987 | 0.080 |
Why?
|
| Interneurons | 1 | 2009 | 22 | 0.080 |
Why?
|
| Temperature | 1 | 2011 | 299 | 0.080 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 738 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 289 | 0.080 |
Why?
|
| Tremor | 1 | 2009 | 23 | 0.080 |
Why?
|
| Mitochondrial Membranes | 1 | 2009 | 4 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 124 | 0.080 |
Why?
|
| SOXE Transcription Factors | 1 | 2009 | 6 | 0.080 |
Why?
|
| Darkness | 1 | 2009 | 22 | 0.080 |
Why?
|
| Carcinoma | 1 | 2010 | 117 | 0.080 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 385 | 0.080 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 1 | 2008 | 5 | 0.080 |
Why?
|
| Armadillo Domain Proteins | 1 | 2009 | 22 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 235 | 0.080 |
Why?
|
| Docosahexaenoic Acids | 2 | 1999 | 31 | 0.080 |
Why?
|
| Smoking | 2 | 2010 | 827 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1033 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2013 | 480 | 0.070 |
Why?
|
| Mitochondrial Proteins | 1 | 2009 | 100 | 0.070 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2008 | 22 | 0.070 |
Why?
|
| Mammals | 2 | 2023 | 209 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2008 | 34 | 0.070 |
Why?
|
| Proteins | 1 | 2013 | 730 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 2 | 2020 | 194 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2009 | 857 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2008 | 254 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 632 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2060 | 0.060 |
Why?
|
| Neural Pathways | 2 | 2017 | 96 | 0.060 |
Why?
|
| Calcium | 2 | 2011 | 557 | 0.060 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2008 | 229 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2011 | 1153 | 0.060 |
Why?
|
| Azocines | 1 | 2004 | 1 | 0.060 |
Why?
|
| Quinolizines | 1 | 2004 | 8 | 0.060 |
Why?
|
| Alkaloids | 1 | 2004 | 11 | 0.060 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2004 | 19 | 0.060 |
Why?
|
| Rats, Wistar | 2 | 2015 | 179 | 0.060 |
Why?
|
| Serine | 1 | 2004 | 85 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2009 | 656 | 0.060 |
Why?
|
| Binding Sites | 2 | 2010 | 882 | 0.060 |
Why?
|
| HEK293 Cells | 2 | 2019 | 588 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2003 | 51 | 0.050 |
Why?
|
| Microinjections | 1 | 2003 | 67 | 0.050 |
Why?
|
| Integrases | 1 | 2023 | 36 | 0.050 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 1 | 2002 | 4 | 0.050 |
Why?
|
| Abnormalities, Multiple | 1 | 2002 | 52 | 0.050 |
Why?
|
| Plasmids | 1 | 2003 | 281 | 0.050 |
Why?
|
| Protein Binding | 2 | 2009 | 1556 | 0.050 |
Why?
|
| Motor Activity | 1 | 2004 | 333 | 0.050 |
Why?
|
| Cadmium | 1 | 2001 | 12 | 0.050 |
Why?
|
| Protein Transport | 1 | 2023 | 399 | 0.050 |
Why?
|
| Xenopus | 1 | 2001 | 54 | 0.050 |
Why?
|
| Base Sequence | 2 | 2002 | 1302 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2002 | 172 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2002 | 94 | 0.050 |
Why?
|
| Long QT Syndrome | 1 | 2001 | 30 | 0.050 |
Why?
|
| alpha7 Nicotinic Acetylcholine Receptor | 2 | 2016 | 7 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2001 | 128 | 0.040 |
Why?
|
| Transfection | 1 | 2003 | 679 | 0.040 |
Why?
|
| Cysteine | 1 | 2001 | 107 | 0.040 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2011 | 16 | 0.040 |
Why?
|
| Ion Channel Gating | 1 | 2000 | 44 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2000 | 112 | 0.040 |
Why?
|
| DNA Primers | 1 | 2000 | 289 | 0.040 |
Why?
|
| Profilins | 1 | 2020 | 45 | 0.040 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 25 | 0.040 |
Why?
|
| Prostaglandins | 1 | 1999 | 17 | 0.040 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 490 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 844 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 91 | 0.040 |
Why?
|
| Kinetics | 1 | 2000 | 751 | 0.040 |
Why?
|
| Brain Chemistry | 2 | 2009 | 76 | 0.040 |
Why?
|
| Dinoprost | 1 | 1998 | 19 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2002 | 678 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2011 | 945 | 0.030 |
Why?
|
| Inactivation, Metabolic | 1 | 2017 | 14 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2011 | 1380 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2017 | 95 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2020 | 727 | 0.030 |
Why?
|
| Transcriptome | 1 | 2019 | 345 | 0.030 |
Why?
|
| Pentobarbital | 1 | 2016 | 4 | 0.030 |
Why?
|
| Azetidines | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2016 | 84 | 0.030 |
Why?
|
| Autoreceptors | 1 | 2015 | 1 | 0.030 |
Why?
|
| Serotonin 5-HT1 Receptor Antagonists | 1 | 2015 | 1 | 0.030 |
Why?
|
| Designer Drugs | 1 | 2015 | 2 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2015 | 6 | 0.030 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 62 | 0.030 |
Why?
|
| Ketamine | 1 | 2016 | 32 | 0.030 |
Why?
|
| Synapses | 1 | 2017 | 179 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2017 | 558 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 58 | 0.030 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2014 | 8 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 89 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2015 | 272 | 0.030 |
Why?
|
| Ligands | 1 | 2014 | 411 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1955 | 0.030 |
Why?
|
| C9orf72 Protein | 1 | 2013 | 104 | 0.020 |
Why?
|
| Liver | 1 | 2017 | 798 | 0.020 |
Why?
|
| Diet | 1 | 2015 | 497 | 0.020 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2011 | 4 | 0.020 |
Why?
|
| Dopamine Agents | 1 | 2011 | 11 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2013 | 139 | 0.020 |
Why?
|
| Serotonin Agents | 1 | 2011 | 10 | 0.020 |
Why?
|
| Staurosporine | 1 | 2011 | 19 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2011 | 42 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2011 | 43 | 0.020 |
Why?
|
| Luciferases | 1 | 2011 | 107 | 0.020 |
Why?
|
| Autocrine Communication | 1 | 2011 | 32 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 89 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 120 | 0.020 |
Why?
|
| Lac Operon | 1 | 2010 | 26 | 0.020 |
Why?
|
| Nitrosamines | 1 | 2010 | 10 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 534 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 387 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2011 | 378 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 560 | 0.020 |
Why?
|
| Cricetulus | 1 | 2009 | 99 | 0.020 |
Why?
|
| Dipeptides | 1 | 2009 | 60 | 0.020 |
Why?
|
| CHO Cells | 1 | 2009 | 189 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 187 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2009 | 149 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2011 | 886 | 0.020 |
Why?
|
| Spine | 1 | 2009 | 42 | 0.020 |
Why?
|
| Cricetinae | 1 | 2009 | 366 | 0.020 |
Why?
|
| Electrophysiology | 1 | 2008 | 88 | 0.020 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2008 | 25 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2008 | 18 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 591 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2013 | 1304 | 0.020 |
Why?
|
| Acetylation | 1 | 2008 | 114 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 62 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2008 | 82 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 620 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1556 | 0.020 |
Why?
|
| Lung | 1 | 2011 | 926 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 349 | 0.020 |
Why?
|
| Histones | 1 | 2008 | 463 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 3629 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2010 | 688 | 0.010 |
Why?
|
| Seizures | 1 | 2003 | 115 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 224 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2002 | 52 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 173 | 0.010 |
Why?
|
| Pedigree | 1 | 2002 | 183 | 0.010 |
Why?
|
| Alzheimer Disease | 2 | 1999 | 682 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2002 | 524 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 18 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1999 | 41 | 0.010 |
Why?
|
| Lipid Peroxidation | 1 | 1999 | 63 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1998 | 68 | 0.010 |
Why?
|
| Swine | 1 | 1998 | 360 | 0.010 |
Why?
|
| Oxidative Stress | 1 | 1999 | 278 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 1998 | 297 | 0.010 |
Why?
|